Sapient Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
5,492
-636
-10% -$176K 0.02% 187
2026
Q1
$1.81M Sell
6,128
-316
-5% -$93.9K 0.03% 162
2025
Q4
$1.78M Buy
6,444
+101
+2% +$27.4K 0.03% 164
2025
Q3
$1.73M Sell
6,343
-117
-2% -$31.8K 0.03% 154
2025
Q2
$1.78M Sell
6,460
-8
-0.1% -$2.18K 0.03% 149
2025
Q1
$1.72M Sell
6,468
-429
-6% -$106K 0.03% 157
2024
Q4
$1.64M Sell
6,897
-1,895
-22% -$436K 0.03% 156
2024
Q3
$1.94M Sell
8,792
-561
-6% -$116K 0.04% 143
2024
Q2
$1.84M Buy
9,353
+7
+0.1% +$1.45K 0.04% 135
2024
Q1
$2.01M Sell
9,346
-234
-2% -$49.2K 0.04% 133
2023
Q4
$2.07M Buy
+9,580
New +$2.04M 0.05% 127

Other funds holding CME

Sapient Capital's CME Position: Q2 2026 in Review

Sapient Capital reduced its CME Group (CME) stake by 10% in Q2 2026, selling an estimated $176K and leaving 5,492 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #187.

Sapient Capital first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.07M in Q4 2023. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sapient Capital held 5,492 shares of CME Group worth $1.21M as of Q2 2026.
  • Sapient Capital sold 636 CME Group shares in Q2 2026, an estimated $176K.
  • CME Group made up 0.02% of Sapient Capital's portfolio in Q2 2026, its #187 holding.
  • Sapient Capital first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's CME Group position peaked at $2.07M in Q4 2023.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.